Log in to save to my catalogue

PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive pat...

PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive pat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2352658977

PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders

About this item

Full title

PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Virchows Archiv : an international journal of pathology, 2020-08, Vol.477 (2), p.269-277

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Carcinoma in situ (CIS) is believed to be a precursor of muscle-invasive carcinomas that may arise from these flat high-grade, superficial urothelial lesions. CIS accounts for approximately 10% of all bladder tumors. Therapeutic options for urothelial CIS are limited, and in order to inhibit disease progression and recurrence, current guidelines re...

Alternative Titles

Full title

PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2352658977

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2352658977

Other Identifiers

ISSN

0945-6317

E-ISSN

1432-2307

DOI

10.1007/s00428-020-02755-2

How to access this item